gefitinib has been researched along with casein kinase ii in 3 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (casein kinase ii) | Trials (casein kinase ii) | Recent Studies (post-2010) (casein kinase ii) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 3,268 | 5 | 1,299 |
| Protein | Taxonomy | gefitinib (IC50) | casein kinase ii (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | 3.57 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.484 | |
| Casein kinase II subunit alpha | Rattus norvegicus (Norway rat) | 0.14 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 2.23 | |
| Cyclin-A2 | Homo sapiens (human) | 2.38 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 2.38 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 2.23 | |
| Casein kinase II subunit beta | Rattus norvegicus (Norway rat) | 0.14 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 2.23 | |
| Cyclin-A1 | Homo sapiens (human) | 2.38 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.26 | |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CM; Choi, YJ; Chun, YJ; Kim, CH; Kim, SY; Kim, WS; Lee, JC; Rho, JK; So, KS; Song, JS | 1 |
| Benveniste, EN; Dees, KJ; Gibson, SA; Hjelmeland, AB; McFarland, BC; Meares, GP; Nozell, SE; Rajbhandari, R; Rowse, AL | 1 |
| Chang, YW; Chen, XJ; Hsu, CL; Huang, HC; Juan, HF; Tang, CW | 1 |
3 other study(ies) available for gefitinib and casein kinase ii
| Article | Year |
|---|---|
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.
Topics: Apoptosis; Autophagy; Casein Kinase II; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Naphthyridines; Phagosomes; Phenazines; Protein Kinase Inhibitors; Quinazolines | 2014 |
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.
Topics: AC133 Antigen; Animals; Brain Neoplasms; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Embryo, Mammalian; Enzyme Inhibitors; Female; Gefitinib; Glioblastoma; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Naphthyridines; Neoplastic Stem Cells; Phenazines; Pregnancy; Quinazolines; RNA, Small Interfering; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Multiomics Reveals Ectopic ATP Synthase Blockade Induces Cancer Cell Death via a lncRNA-mediated Phospho-signaling Network.
Topics: Antineoplastic Agents; Apoptosis; ATP Synthetase Complexes; Carcinoma, Non-Small-Cell Lung; Casein Kinase II; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Gefitinib; Gene Ontology; Humans; Immunohistochemistry; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Phosphorylation; Protein Kinase Inhibitors; Proteomics; RNA, Long Noncoding; RNA, Small Interfering; Signal Transduction; Tandem Mass Spectrometry; Tumor Suppressor Protein p53 | 2020 |